ResMed beats quarterly profit estimates on demand for sleep disorder devices
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Future Market Insights1d
Sleep Apnea Devices Market to Reach USD 20.4 Billion by 2033 at a 9.5% of CAGR, Amid Rising Awareness and Technological Advancements
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...
Sponsored content: Sleep Stratford – Dr. Zach Korwin Discusses Options for Treating Sleep Apnea
On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...
Can the right pillow really help reduce sleep apnea symptoms? Yes, here's how
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...